跳至主要内容
临床试验/NCT01620567
NCT01620567已完成不适用

The Effect of Consumption of Potatoes, Avocados and Chickpeas Daily for 6 Months on Cognitive Function in Older Adults

Tufts University1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2012年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
1
主要终点
Cognition

研究概览

简要总结

Cognitive impairment is also a major risk factor for development of dementia later in life. Findings from the investigators studies suggest that the carotenoids, lutein and zeaxanthin may be important in cognitive function in the elderly. Avocados are a source of these carotenoids. The investigators study evaluates long-term avocado intervention as a treatment strategy for age-related cognitive impairment which could possibly prevent the onset of dementia. The investigators have also shown that lutein supplementation significantly improved verbal fluency scores in healthy older women. Based on these findings, the next logical step will be to investigate the ability of lutein and zeaxanthin contained in avocados to influence cognitive function in older adults. The investigators hypothesize that there will be a significant increase in cognitive function measures in older adults provided with meals containing 1 avocado/day at the end of 6 months, while no significant improvements will be observed in older adults given daily meals containing chickpeas and/or potatoes.

The proposed study is designed as a randomized, placebo controlled trial that tests the effects of 6 month supplementation with 1 avocado/day on cognitive function in older adults. Secondary analyses will determine whether baseline macular pigment (lutein in retina which canbe measured non invasivley) density predicts relative effectiveness of the intervention on cognitive function. Secondary outcomes include plasma biomarkers of oxidative stress and inflammation.

详细描述

The study is designed as a placebo controlled trial that tests the effects of 6 month supplementation with daily meals containing 1 avocado or isocaloric amounts of chickpeas and/or potatoes on cognitive function in older adults. Subjects will be randomly assigned to one of the two groups. Secondary analyses will determine whether baseline macular pigment density (a non invasive measure of lutein and zeaxanthin in neural tissue) predicts relative effectiveness of the intervention on cognitive function. Secondary outcomes include plasma biomarkers of oxidative stress and inflammation. Participants will be recruited from community-dwelling men and women aged >50 yr, and potential participants will be screened to meet cognitive and functional criteria. Participants will be pre-screened by telephone; those who appear to meet criteria will undergo further screening. The study will include baseline (0 month), 3 and 6 month visits for study procedures, and monthly telephone calls. Given that there is a visible difference between the two interventions, a blinded study is not possible.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •men and women age > 50 years
  • •BMI 19-30 kg/m2
  • •lutein intake of < 3 mg/d
  • •Docosahexaenoic acid intake < 250 mg/d (including supplements)
  • •Mini mental state exam (MMSE) score > 24
  • •Macular pigment density < 0.4 at 0.5 degrees
  • •Beck Depression Inventory < 20
  • •free of known disease
  • •BMI 19-29 kg/m2
  • •must be able to give written informed consent
  • •have normal hematologic parameters
  • •normal values of plasma albumin
  • •normal values for liver and kidney function (Appendix A)
  • •no use of carotenoid, n3 fatty acid, multivitamin/mineral, (> 2 months).

排除标准

  • •history of active small bowel disease or resection
  • •atrophic gastritis
  • •hyperlipidemia (LDL >120 mg/dL or triglycerides >150 mg/dL)
  • •hypertension (>150/90 mm Hg)
  • •diabetes, alcoholism (>2 drinks/d or 14 drinks/week)
  • •pancreatic disease
  • •anemia, and bleeding disorders (as determined by screening interview)
  • •avocado, potato or chickpea allergy
  • •pregnancy or lactation
  • •diseases that interfere with fat absorption, e.g. colitis, celiac disease, Crohn's disease, cystic fibroids (as determined by screening interview)
  • •medications that interfere with fat absorption, e.g. bile sequestrants (as determined by screening interview)
  • •use of antipsychotic, antimanic, anti-inflammatory, monoamine inhibitors, or dementia medications
  • •smoking or use of nicotine patches or gum (within past 6 months)
  • •use of drugs suspected of interfering with metabolism of blood clotting, e.g. warfarin (as determined by screening interview)
  • •subjects having extremely high dietary intakes of carotenoids as indicated by screening plasma values > NHANES 95th percentile for lutein/zeaxanthin, beta-carotene, cryptoxanthin, or lycopene
  • •stroke,head injury with loss of consciousness or seizures.
  • •Non English speaking: This is a small study with a sample size. Logistically and financially, getting materials translated for such a small study is not feasible.

研究组 & 干预措施

chickpeas/potatoes

Placebo Comparator

1 potato/day or 1 cup chickpeas

干预措施: potato or chickpea (Other)

avocados

Active Comparator

1 avocados/day

干预措施: avocado (Other)

结局指标

主要结局

Cognition

时间窗: 6 months

measures of sustained attention will be made using CANTAB, a sensitive computerized program. Signal detection measured on a scale from 0 to 1(bad to good).

次要结局

  • Inflammation(6 month)
  • Inflammation(0 months)
  • Inflammation(3 month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验